Outbreak of mumps associated with poor vaccine efficacy - Oporto Portugal 1996
Author(s) -
Guilherme Gonçalves,
A de Araújo,
M. L. Monteiro Cardoso
Publication year - 1998
Publication title -
eurosurveillance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.766
H-Index - 104
eISSN - 1560-7917
pISSN - 1025-496X
DOI - 10.2807/esm.03.12.00101-en
Subject(s) - vaccination , measles mumps rubella vaccine , medicine , mmr vaccine , rubella vaccine , rubella , measles , outbreak , environmental health , virology , pediatrics , mumps vaccine , immunization , immunology , antigen
Vaccination against mumps in Portugal began in 1987, with the introduction of the combined measles, mumps, and rubella vaccine (MMR) in the national vaccination programme (Programa Nacional de Vacinação: PNV) for both sexes at 15 months. In November 1990,
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom